Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07784192 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pericapsular Nerve Group Block Versus Intrathecal Morphine for Pain After Hip Surgery

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
  2. Minor Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion date: Sep 18, 2026 to Oct 4, 2026
    • Study completion date: Sep 25, 2026 to Oct 7, 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 5 of 7 entries
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  3. Notable Recruitment opened
    • Study sites: 0 to 1
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pain after hip replacement surgery is often severe and is commonly treated with opioids, which may cause nausea, vomiting, sedation, difficulty passing urine and slow breathing. This study will compare two ways of controlling pain in adults having hip surgery under spinal anesthesia. One group will receive morphine added to the spinal injection. The other group will receive an ultrasound-guided pericapsular nerve group (PENG) block, in which local anesthetic is injected near the nerves that carry pain signals from the hip joint. Participants will be assigned to one of the two groups by chance. Sixty-four adults aged 18 to 65 years will take part, with 32 in each group. Pain scores at rest and during movement, the total amount of morphine used through a patient-controlled pump, the time until the first request for extra pain medicine, the amount of additional paracetamol used, side effects such as nausea and vomiting, and complications related to the block will be compared between the groups during the first 48 hours after surgery.
Trial Details
NCT Number NCT07784192
Lead Sponsor Selcuk University
Conditions
(from sponsor)
Hip Arthroplasty, Total, Postoperative Pain, Hip Arthroplasty, Analgesia, Hip Fractures (ICD-10 72.01-72.2)
Related terms Agnosia, Hip Fractures, Postoperative Pain
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov